Dual ultrastructural localization of mu-opiate receptors and substance P in the dorsal horn

Citation
Sa. Aicher et al., Dual ultrastructural localization of mu-opiate receptors and substance P in the dorsal horn, SYNAPSE, 36(1), 2000, pp. 12-20
Citations number
48
Categorie Soggetti
Neurosciences & Behavoir
Journal title
SYNAPSE
ISSN journal
08874476 → ACNP
Volume
36
Issue
1
Year of publication
2000
Pages
12 - 20
Database
ISI
SICI code
0887-4476(200004)36:1<12:DULOMR>2.0.ZU;2-F
Abstract
actions involving substance P (SP), a peptide present in both unmyelinated primary afferents and interneurons within the dorsal horn. We examined pote ntial functional sites for interactions between SP and MOR by using dual el ectron microscopic immunocytochemical localization of antisera against SP a nd a sequence-specific antipeptide antibody against MOR in rat cervical spi nal dorsal horn. The distribution was compared with that of the functionall y analogous dorsal horn of the trigeminal nucleus caudalis. Many of the SP- immunoreactive terminals in the dorsal horn contacted dendrites that contai n MOR (53% in trigeminal; 70% in cervical spinal cord). Conversely, within the cervical spinal dorsal horn 79% of the MOR-labeled dendrites that recei ved any afferent input were contacted by at least one SP-containing axon or terminal. Although SP-immunoreactive dendrites were rare, many of these (4 8%) contained MOR, suggesting that the activity of SP-containing spinal int erneurons may be regulated by MOR ligands. A few SP-labeled terminals also contained MOR (12% in trigeminal; 6% in cervical spinal cord). These data s upport the idea that MOR ligands produce antinociception primarily through modulation of postsynaptic second-order nociceptive neurons in the dorsal h orns of spinal cord and spinal trigeminal nuclei, some of which contain SP, They also suggest, however, that in each region, MOR agonists can act pres ynaptically to control the release of SP and/or glutamate from afferent ter minals. The post- and presynaptic MOR sites are likely to account for the p otency of MOR agonists as analgesics. (C) 2000 Wiley-Liss, Inc.